Anti-inflammatory effects of thymoquinone and its protective effects against several diseases

Biomed Pharmacother. 2021 Jun:138:111492. doi: 10.1016/j.biopha.2021.111492. Epub 2021 Mar 17.

Abstract

Thymoquinone (TQ, 2-methyl-5-isopropyl-1, 4-benzoquinone), a monoterpene molecule present in Nigella sativa L., has an anti-inflammatory, anti-oxidant, and anti-apoptotic properties in several disorders such as asthma, hypertension, diabetes, inflammation, bronchitis, headache, eczema, fever, dizziness and influenza. TQ exerts its anti-inflammatory and anti-oxidant effects via several molecular pathways, including the release of cytokines, and activation of cyclooxygenase-2 (COX2), nuclear factor erythroid 2-related factor 2 (Nrf2), phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT), nuclear factor kappa-light-chain-enhancer of activated B (NF-Κβ). In this review, recent reports on the anti-inflammatory efficacy of TQ in heart disorders, respiratory diseases, neuroinflammation, diabetes and arthritis are summarized. We suggest that further investigation is necessary to better characterize the efficacy of TQ as a therapeutic agent.

Keywords: Inflammation; Signaling pathways; Thymoquinone.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use*
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Benzoquinones / pharmacology*
  • Benzoquinones / therapeutic use*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / prevention & control
  • Cytoprotection / drug effects*
  • Cytoprotection / physiology
  • Humans
  • Inflammation Mediators / antagonists & inhibitors*
  • Inflammation Mediators / metabolism
  • Metabolic Diseases / metabolism
  • Metabolic Diseases / prevention & control

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Benzoquinones
  • Inflammation Mediators
  • thymoquinone